Despite VCs investing $75B in Q4 , it’s still hard for startups to raise money, data proves
After two years of relatively muted investment activity, it seems that VCs are starting to pour capital into startups at ...
Tempus AI: Disappointing Q4 Preliminary Results, But Bullish Fundamental Update
Tempus AI is a leading player in healthcare AI, aiming to deliver personalized treatment suggestions. Read why I think TEM ...
Hedge Fund Investor Letters Q4 2024
We will be sharing Q4 2024 hedge fund investor letters in this article. You can also see the hedge fund investor letters for ...
JD Supra6d
Q4 2024 Health Care Conference Roundup: AI and Government Enforcement Are on the Rise
Last quarter, our attorneys had the privilege of attending three prominent health care conferences, each of which offered a ...
TSMC Q4: Expecting Fabless Semi Inventory To Return To Healthier Level In 2025
TSMC's revenue from AI accelerators tripled in FY24 and is expected to double in FY25, supported by increased CAPEX for advanced technologies. Learn more on TSM stock here.
Tempus AI sees Q4 revenue $200M, consensus $206.07M
Sees Q4 revenue of approximately $200M, an increase of approximately 35% year-over-year; Continued trend of sequential improvement in adjusted ...